Endocannabinoid genetic variation enhances vulnerability to THC reward in adolescent female mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32095523.
- Also identified by DOI 10.1126/sciadv.aay1502 and PMC identifier 7015690.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adolescence represents a developmental period with the highest risk for initiating cannabis use. Little is known about whether genetic variation in the endocannabinoid system alters mesolimbic reward circuitry to produce vulnerability to the rewarding properties of the exogenous cannabinoid Δ<sup>9</sup>-tetrahydrocannabinol (THC). Using a genetic knock-in mouse model (FAAH<sup>C/A</sup>) that biologically recapitulates the human polymorphism associated with problematic drug use, we find that in adolescent female mice, but not male mice, this FAAH polymorphism enhances the mesolimbic dopamine circuitry projecting from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and alters cannabinoid receptor 1 (CB<sub>1</sub>R) levels at inhibitory and excitatory terminals in the VTA. These developmental changes collectively increase vulnerability of adolescent female FAAH<sup>C/A</sup> mice to THC preference that persists into adulthood. Together, these findings suggest that this endocannabinoid genetic variant is a contributing factor for increased susceptibility to cannabis dependence in adolescent females.
Medical subject headings
- Aging
- Dronabinol
- Endocannabinoids
- Genetic Variation
- Reward